Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Genomic changes in urinary bladder cancer]

G Sauter1, H Moch, U Wagner

  • 1Institut für Pathologie, Universitätsspitals Basel.

Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A stratified two-stage tumor molecular profiling algorithm to identify clinically actionable molecular alterations in pancreatic cancer.

ESMO gastrointestinal oncology·2026
Same author

Advancing Lung Cancer Staging: Integrating IASLC Recommendations and Bioinformatics to Delineate Tumor Origins.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025
Same author

Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

From wind to seismic signature captured by seismometers in lake Lucerne.

Scientific reports·2025
Same author

Unravelling lung adenocarcinoma with mucinous histology and its translational implications.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study.

ESMO open·2023
Same journal

[The PEA-15 protein induces resistance against glucose deprivation-induced cell death via the ERK/MAP kinase pathway].

Verhandlungen der Deutschen Gesellschaft fur Pathologie·2008
Same journal

[Methylation status of LINE-1 sequences in patients with MDS or secondary AML].

Verhandlungen der Deutschen Gesellschaft fur Pathologie·2008
Same journal

[Heat shock protein 90 alpha und beta are overexpressed in multiple myeloma cells and critically contribute to survival].

Verhandlungen der Deutschen Gesellschaft fur Pathologie·2008
Same journal

[Gastrin cell hyperplasia associated with duodenal MEN1-related gastrinomas: histopathology and genetics].

Verhandlungen der Deutschen Gesellschaft fur Pathologie·2008
Same journal

Artificial intelligence and bladder cancer arrays.

Verhandlungen der Deutschen Gesellschaft fur Pathologie·2008
Same journal

[Mapping of a deletion interval on 8p21-22 in prostate cancer by gene dosage PCR].

Verhandlungen der Deutschen Gesellschaft fur Pathologie·2008
See all related articles

Urinary bladder cancer exhibits two distinct genetic profiles: stable tumors (pTa) with minimal alterations and unstable tumors (pT1-4) showing significant genomic changes. These genetic differences may refine cancer classification and treatment strategies.

Area of Science:

  • Urothelial Carcinomas
  • Cancer Genomics
  • Molecular Oncology

Context:

  • Transitional cell carcinoma (TCC) of the urinary bladder is a significant health concern.
  • Existing classifications rely on pathological (pTNM) and clinical staging (superficial vs. invasive).
  • Molecular heterogeneity within TCC suggests distinct genetic underpinnings.

Purpose:

  • To investigate the genomic differences between non-invasive (pTa) and invasive (pT1-4) urinary bladder tumors.
  • To identify specific genetic alterations associated with tumor stability and instability.
  • To explore the potential of genetic profiling in improving bladder cancer classification.

Summary:

  • Genetically stable tumors (pTa, grade 1-2) show few alterations, typically involving chromosomes Y and 9 losses, and 1q gains, with rare p53 mutations.

Related Experiment Videos

  • Genetically unstable tumors (pT1-4) exhibit frequent p53 alterations and numerous copy number changes, including deletions (2q, 5q, 6q, 8p, 11p) and gains (1q, 3p, 3q, 5p, 6p, 8q, 10p).
  • High-level amplifications are common in unstable tumors, potentially indicating oncogene activation.

    • Impact:

    • Identifies distinct genomic profiles correlating with tumor invasiveness in urinary bladder cancer.
    • Suggests that genetic analysis could complement current pathological and clinical staging systems.
    • Provides a foundation for future research into targeted therapies based on specific genomic alterations.